---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-011797"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2025-10-15T23:59:59+00:00"
generated_at: "2026-05-17T03:45:11.607962+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ENDRA raises $4.9M in private placement to launch digital asset treasury strategy managed by Arca

## Summary
- Gross proceeds of ~$4.9M from sale of 744,340 shares/prefunded warrants and warrants at $6.57 per unit; potential $14.4M if all warrants exercised.
- Majority of net proceeds to establish a digital asset treasury (DAT) investing in decentralized finance, starting with HYPE; managed by Arca Investment Management.
- Up to $1M of proceeds allocated for TAEUS pilot validation imaging study for MASLD/MASH; balance for working capital.
- Jeff Dorman, Arca's CIO, appointed to Digital Asset Advisory Board; ATM agreement with Ascendiant terminated.
- 2025 annual meeting set for Dec 9, 2025; record date Oct 16, 2025; stockholder proposal deadline Oct 27, 2025.

## SEC filing metadata
- accession: 0001654954-25-011797
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2025-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 1.02, 3.02, 5.08, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495425011797/0001654954-25-011797-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495425011797/endra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-011797
- JSON: https://secwatch.observer/filing/0001654954-25-011797.json
- Plain text: https://secwatch.observer/filing/0001654954-25-011797.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.